AMILORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Amiloride patents expire, and when can generic versions of Amiloride launch?
Amiloride is a drug marketed by Chartwell Rx, Ph Health, Sigmapharm Labs Llc, Barr, Rising, Teva, and Watson Labs. and is included in eight NDAs.
The generic ingredient in AMILORIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amiloride
A generic version of AMILORIDE was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMILORIDE?
- What are the global sales for AMILORIDE?
- What is Average Wholesale Price for AMILORIDE?
Summary for AMILORIDE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for AMILORIDE |
| DailyMed Link: | AMILORIDE at DailyMed |


